insurers glp-1 coverage news BREAKING NEWS! insurance companies DROPPING GLP1 Coverage?! Ro launches GLP-1 insurance coverage

GLP-1RA Liraglutide Semaglutide Efpeglenatide Glucose lowering effect CV system protection effect Kidney protection effect Nonalcoholic fatty liver disease GIP/GLP1 receptor coagonists: tirzepatide Amylin/GLP1 receptor coagonists: CagriSema (cagrilintide+semaglutide) Glucagon/GLP1 receptor coagonists: survodutide GIP/GLP1/glucagon receptor triple coagonists: retatrutide Obesity is a disease that can be treated with targeted pharmacotherapy in addition to lifestyle modification and behavioral interventions

The term microdosing probably makes you think of psychedelic drugs us too

Boosted mental well-being: Achieving weight loss goals can positively impact mood and self-esteem

Semaglutide at therapeutic doses reduces A1c by 1.0 to 1.5 percentage points on average

Song et al., 2016)

However, patients in more advanced stages or those on dialysis require more frequent evaluations, especially during dose adjustments